Similarly, another PSMA-targeting radioligand ([177Lu]Lu-RPS-63) equipped with the p-iodobenzoate-based albumin binder accumulated faster in the tumor than its analog ([177Lu]Lu-RPS-72) derivatized with a stronger albumin binder [33]. This evidence concerns the gene FOLH1 and neoplasm.